Citalopram
Suicidal Thoughts and Behaviors
- Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants.
- Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors (5.1)
- This drug is not approved for use in pediatric patients(8.4).
MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA
- Close observation for suicidal thinking or unusual changes in behavior
FDA and Industry Communications
Drug Safety Communication: Abnormal Heart Rhythm Associated with High Doses (Aug 2011)
FDA Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults
Patient Counseling Information
Medication Guides
Package Inserts
Additional Information
Updated February 2022